GB0212036D0 - Vaccines - Google Patents

Vaccines

Info

Publication number
GB0212036D0
GB0212036D0 GBGB0212036.8A GB0212036A GB0212036D0 GB 0212036 D0 GB0212036 D0 GB 0212036D0 GB 0212036 A GB0212036 A GB 0212036A GB 0212036 D0 GB0212036 D0 GB 0212036D0
Authority
GB
United Kingdom
Prior art keywords
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0212036.8A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0212036.8A priority Critical patent/GB0212036D0/en
Publication of GB0212036D0 publication Critical patent/GB0212036D0/en
Priority to US10/515,872 priority patent/US20060062798A1/en
Priority to EP03735479A priority patent/EP1507861A2/en
Priority to AU2003237701A priority patent/AU2003237701A1/en
Priority to JP2004506720A priority patent/JP2005526511A/ja
Priority to CA002485733A priority patent/CA2485733A1/en
Priority to PCT/EP2003/005595 priority patent/WO2003099193A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727—Mucins, e.g. human intestinal mucin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
GBGB0212036.8A 2002-05-24 2002-05-24 Vaccines Ceased GB0212036D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB0212036.8A GB0212036D0 (en) 2002-05-24 2002-05-24 Vaccines
US10/515,872 US20060062798A1 (en) 2002-05-24 2003-05-23 Vaccines
EP03735479A EP1507861A2 (en) 2002-05-24 2003-05-23 Vaccines
AU2003237701A AU2003237701A1 (en) 2002-05-24 2003-05-23 Vaccines
JP2004506720A JP2005526511A (ja) 2002-05-24 2003-05-23 ワクチン
CA002485733A CA2485733A1 (en) 2002-05-24 2003-05-23 Vaccines
PCT/EP2003/005595 WO2003099193A2 (en) 2002-05-24 2003-05-23 Vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0212036.8A GB0212036D0 (en) 2002-05-24 2002-05-24 Vaccines

Publications (1)

Publication Number Publication Date
GB0212036D0 true GB0212036D0 (en) 2002-07-03

Family

ID=9937387

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0212036.8A Ceased GB0212036D0 (en) 2002-05-24 2002-05-24 Vaccines

Country Status (7)

Country Link
US (1) US20060062798A1 (https=)
EP (1) EP1507861A2 (https=)
JP (1) JP2005526511A (https=)
AU (1) AU2003237701A1 (https=)
CA (1) CA2485733A1 (https=)
GB (1) GB0212036D0 (https=)
WO (1) WO2003099193A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0212046D0 (en) * 2002-05-24 2002-07-03 Glaxo Group Ltd Vaccines
GB0304634D0 (en) * 2003-02-28 2003-04-02 Glaxo Group Ltd Vaccines
JP5060134B2 (ja) * 2003-12-12 2012-10-31 ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ・アズ リプレゼンテッド バイ ザ セクレタリー・デパートメント オブ ヘルス アンド ヒューマン サービシーズ ヒト細胞傷害性Ｔリンパ球のエピトープ及びそのＭＵＣ−１の非ＶＮＴＲ（ｎｏｎ−ｖａｒｉａｂｌｅｎｕｍｂｅｒｏｆｔａｎｄｅｍｒｅｐｅａｔｓｅｑｕｅｎｃｅ）由来のアゴニストエピトープ
CA2595778A1 (en) * 2005-01-28 2006-08-03 Ramot At Tel Aviv University, Ltd. Anti-muc1 .alpha..beta. antibodies
US9140692B1 (en) * 2010-01-08 2015-09-22 Glycozym, Inc. Methods of identifying glycopeptides recognized by disease-associated auto-antibodies

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744144A (en) * 1993-07-30 1998-04-28 University Of Pittsburgh University Patent Committee Policy And Procedures Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof
AUPM322393A0 (en) * 1993-12-24 1994-01-27 Austin Research Institute, The Mucin carbohydrate compounds and their use in immunotherapy
US6548643B1 (en) * 1994-11-16 2003-04-15 Austin Research Institute Antigen carbohydrate compounds and their use in immunotherapy
EP1012276A2 (en) * 1997-02-24 2000-06-28 Therion Biologics Corporation Recombinant pox virus for immunization against muc1 tumor-associated antigen
IL125608A0 (en) * 1998-07-30 1999-03-12 Yeda Res & Dev Tumor associated antigen peptides and use of same as anti-tumor vaccines
US6228843B1 (en) * 1999-04-23 2001-05-08 University Technology Corporation Method of using PKC inhibiting compounds to treat vascular disease
JP2003510094A (ja) * 1999-09-08 2003-03-18 トランジェーヌ、ソシエテ、アノニム Ｍｕｃ−１由来のペプチド
GB9930359D0 (en) * 1999-12-22 2000-02-09 Glaxo Group Ltd Novel polypeptides
EP1257565A4 (en) * 2000-02-01 2005-04-06 Austin Research Inst DERIVED FROM MUCIN-1 ANTIGENE AND ITS USE IN IMMUNOTHERAPY
US7125663B2 (en) * 2001-06-13 2006-10-24 Millenium Pharmaceuticals, Inc. Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
GB0212046D0 (en) * 2002-05-24 2002-07-03 Glaxo Group Ltd Vaccines

Also Published As

Publication number Publication date
JP2005526511A (ja) 2005-09-08
CA2485733A1 (en) 2003-12-04
WO2003099193A3 (en) 2004-02-19
WO2003099193A2 (en) 2003-12-04
US20060062798A1 (en) 2006-03-23
AU2003237701A1 (en) 2003-12-12
AU2003237701A8 (en) 2003-12-12
EP1507861A2 (en) 2005-02-23

Similar Documents

Publication Publication Date Title
GB0213622D0 (en) Vaccine Corporation
GB0226722D0 (en) Vaccine
GB0202901D0 (en) Novel vaccine
GB0225788D0 (en) Vaccine
AU2003285320A8 (en) Vaccine
GB0212046D0 (en) Vaccines
GB0228715D0 (en) Vaccine
GB0323840D0 (en) Vaccines
GB0218921D0 (en) Novel vaccine
GB0209878D0 (en) Vaccine
PL376534A1 (pl) Szczepionka
GB0321614D0 (en) Vaccines
GB0304634D0 (en) Vaccines
AU2003237701A8 (en) Vaccines
IL156434A0 (en) Vaccine
GB0206595D0 (en) Vaccine
GB0223355D0 (en) Vaccine
GB0226179D0 (en) Vaccine
GB0330007D0 (en) Vaccines
GB0206462D0 (en) Vaccines
GB0217721D0 (en) Vaccines
GB0200829D0 (en) Vaccines
GB0220212D0 (en) Vaccine
GB0213364D0 (en) Vaccine
GB0206054D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)